HIV Epidemics in the European Region (Vulnerability and Response)

HIV Epidemics in the European Region: Vulnerability and Response provides a systematic review of the evidence on HIV vulnerability and response in all 53 countries of the World Health Organization’s (WHO’s) European Region, stretching from Iceland to the borders of China. The report focuses on key populations most at risk of HIV infection: people who inject drugs, sex workers, and men who have sex with men. It confirms that these populations are disproportionately affected by the growing HIV epidemic in Europe. Twenty-five percent of HIV diagnoses in Europe are associated with injecting drug use, with much higher proportions in Eastern Europe (33 percent) than in Western Europe (5 percent) and Central Europe (7 percent). Sex between men accounted for 10 percent of all HIV diagnoses, with higher rates reported in Western Europe (36 percent), followed by Central Europe (22 percent) and Eastern Europe (0.5 percent). HIV remains relatively low among female sex workers who do not inject drugs (less than 1 percent), but higher among those who inject drugs (more than 10 percent) and among male and transgender sex workers. The analysis highlights the pivotal role of social and structural factors in shaping HIV epidemics and HIV prevention responses. Poverty, marginalization, and stigma contribute to the HIV epidemic in Europe and Central Asia. Economic volatility and recession risks are increasing vulnerability to HIV and infections. Barriers to successful HIV responses include the criminalization of sex work, of sex between men, and of drug use combined with social stigmatization, violence, and rights violations. HIV prevention requires social and environmental change. The report calls for policy makers and HIV program implementers to target the right policies and programs to maximize the health and social impacts of Europe’s HIV responses and get higher returns on HIV-related investments. HIV Epidemics in the European Region: Vulnerability and Response is a product of a collaboration between the World Bank, the London School of Hygiene and Tropical Medicine, the WHO Regional Office for Europe, and UNAIDS.